Given its dual regulatory roles in tumor biology and immune modulation, targeting Piezo1—such as through combination with programmed death-1 (PD-1) blockade—offers a potential strategy to reverse immunosuppression and enhance antitumor immunity. The gene discussed is PIEZO1; the disease is neoplasm.